Objective:
To describe the prevalence and phenotypic characteristics of small eyes in the EPIC-Norfolk Eye Study.
Design:
Community cross-sectional study.
Setting:
East England population (Norwich, Norfolk and surrounding area).
Participants:
8033 participants aged 48-91 years old from the EPIC-Norfolk Eye Study, Norfolk, United Kingdom with axial length measurements. Participants underwent a standardized ocular examination including visual acuity (LogMAR), ocular biometry, non-contact tonometry, auto-refraction and fundal photography. A small eye phenotype was defined as a participant with one or both eyes with axial length of <21.00mm.
Outcome measures:
Prevalence of small eyes, proportion with visual impairment, demographic and biometric factors.
Results:
Ninety-six participants (1.20%, 95% CI: 0.98 to 1.46) had an eye with axial length less than 21.00mm, of which 74 (77%) were female. Prevalence values for shorter axial lengths were <20.00mm: 0.27% (0.18 to 0.41); <19.00mm: 0.17% (0.11 to 0.29); <18.00mm: 0.14% (0.08 to 0.25). Two participants (2.1%) had low vision (presenting visual acuity >0.48 LogMAR) and 1 participant was blind (>1.3 logMAR). The prevalence of unilateral visual impairment was higher in participants with a small eye. Multiple logistic regression modeling showed presence of a small eye to be significantly associated with shorter height, lower body mass index, higher systolic blood pressure and lower intraocular pressure.
Conclusions:
The prevalence of people with small eyes is higher than previously thought.
Whilst small eyes were more common in women, this appears to be related to shorter height and lower body mass index. Participants with small eyes were more likely to be blind or to have unilateral visual impairment. Article focus:
• The European Prospective Investigation of Cancer-Norfolk Eye Study is part of a European population-based cohort study, with participants now aged 48-92 years old.
• This paper describes the prevalence of small eyes, proportion with visual impairment, and associated demographic and biometric factors.
Key messages:
• Ninety-six participants out of 8033 (1.20%, 95% CI: 0.98 to 1.46) had an eye with axial length less than 21.00mm, of which 74 (77%) were female.
• People with small eyes appear more likely to be blind or have unilateral visual impairment. Presence of a small eye is associated with shorter height, lower body mass index, higher systolic blood pressure and lower intraocular pressure.
• There are no standardized definitions for microphthalmos or nanophthalmos Strengths and limitations of this study:
• Large population based study sample.
• The included population sample may have healthy volunteer bias.
• The identified associations are cross-sectional rather than longitudinal. The small eye phenotype ranges from anophthalmos to nanophthalmos and microphthalmos. The latter two conditions are typically considered to be synonymous 1 and are subdivided into simplex 2 and complex 3 depending on the presence of other associated ocular or systemic abnormalities. There is minimal adult data on the prevalence of this phenotype with estimated birth prevalences for microphthalmos being 0.002 to 0.017%; 4 and 0.009% for microphthalmos in China from mass screening programs. 5 Data from a hospital cohort suggests patients with simple microphthalmos comprise between 0.05% and 0.11% ophthalmic patients. 6 There is great heterogeneity in the definition of nanophthalmos and microphthalmos which complicates interpretation of previous studies, 2,7-12 with a definition by axial length <21.00mm being the most inclusive. [10] [11] [12] Nanophthalmos / microphthalmos is associated with angle closure glaucoma; 1, 13 and also with significant visual morbidity. In a recent series of nanophthalmic individuals from a Melanese population almost half had either unilateral or bilateral visual impairment.
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There is a paucity of data for comparison. In view of this, we report data on the prevalence and characteristics of small eyes in British adults in the EPICNorfolk Eye Study, and review the definitions used for microphthalmos and nanophthalmos.
Method:
EPIC (European Prospective Investigation of Cancer) is a pan-European study that started in 1989 with the primary aim of investigating the relationship between diet and cancer risk. 14 The aims of the EPIC-Norfolk cohort were subsequently broadened to include additional endpoints and exposures such as lifestyle and other environmental factors. 15 The EPIC-Norfolk cohort was The third health examination was reviewed and approved by the East Norfolk 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41 A small eye was defined by an axial length of <21.0mm in at least one eye in keeping with the broadest previously accepted definition for microphthalmos / nanophtahlamos [10] [11] [12] and being equivalent to 2SD below the population mean To allow comparison with previous publications we defined blindness as a presenting visual acuity ≥1.3 logMAR in the better eye and low vision as a presenting visual acuity of >0.48 in the better eye (i.e. combination of moderate and severe visual impairment categories). Unilateral visual impairment was defined by using the eye with worse presenting visual acuity.
Statistical analysis was performed using SPSS version 20. Testing of normality was performed by the Kolmogorow-Smirnov method. Comparisons between participants with and without previous lens extraction were performed using the independent samples t-test or Mann-Whitney U test.
Logistic regression was used to identify factors associated with presence of a small eye and Fisher's exact test to compare presence of visual impairment with the presence of a small eye.
Results.
Partial coherence interferometry data was available on 15,881 eyes of 8,033
participants, of which 4,442 participants were female (55.3%). Case numbers and overall prevalence values for small eyes stratified by axial length value are shown in table 1 and figure 1. Of the 8033 participants with axial length data, visual acuity measurements were available on 8016 (99.8%). Of the 96 participants, 20 were pseudophakic in both eyes, 6 were pseudophakic in one eye, 1 was aphakic in both eyes (congenital cataracts and nystagmus) and 1 aphakic in one eye and pseudophakic in the other.
Defined by smallest eye, 26 participants had undergone previous lens extraction. Fourteen participants (15%) had a history of amblyopia or previous squint surgery. Seven participants (7%) had a history of previous laser iridotomy or surgical iridectomy. Table 2 shows the demographic and biometric characteristics of those with axial length <21.00mm. logMAR in the better eye to allow comparison with previous visual impairment studies, the prevalence was 5/96 (5.2%). The prevalence of blindness was significantly higher in EPIC-Norfolk participants with at least one eye of axial length <21.00mm compared to those without, whilst the overall prevalence of low vision was similar (Table 4 ). Unilateral visual impairment by all definitions was more common in EPIC-Norfolk participants with at least one small eye compared to those without (P≤0.001, Table 4 ). 
Discussion:
There is minimal data describing the prevalence or characteristics of small eyes. In the EPIC-Norfolk Eye Study, the prevalence of a participant with an eye of axial length of <21.00mm was 1.20%, and 0.27% for those with an eye of axial length <20.00mm. Relative to existing data with estimated birth prevalences for microphthalmos being 0.002% to 0.017%; 4,5 and the prevalence of simple microphthalmos in hospital ophthalmic patients being between 0.05% and 0.11%; 6 small eyes are more common than previously reported.
Nanophthalmos is traditionally associated with a high prevalence of angle closure glaucoma 1, 13 and both nanophthalmos and primary angle closure glaucoma have similar ocular phenotypes including a short axial length, showed that for small discs (1.2mm vertical diameter) in non-glaucomatous eyes, the 97.5th percentile for VCDR was 0.60 (99th percentile: 0.62) whilst corresponding values for large optic discs (1.9mm diameter) were 0.75 and 0.83 respectively. Thus our prevalence of 6.6% should be considered as a minimum prevalence estimate for glaucoma in small eyes, and is likely to include those at highest risk for visual impairment over their lifetime. 21 Review of recent studies reporting on nanophthalmos / microphthalmos shows great heterogeneity in the definitions used, with cases defined primarily by short axial length with for example, values of <21.0mm, 10-12 <20.9mm, 2 <20.5mm, 7 <20.0mm, 8 <18mm 2 or <17mm. 9 The original description of nanophthalmos (or pure microphthalmos) by Duke-Elder 1 is an eye "reduced in volume without the presence of other gross congenital abnormalities,"
"typical dimensions are 16-18.5mm sagittal," "hyperopia is the rule" and "the anterior chamber is typically shallow." The partial relaxation of the definition to its currently accepted form (of at least an axial length of <21.00mm) is likely due to the rarity of the condition. If an abnormally short eye is defined based on the lower 2SD and 3SD limits of mean population axial lengths, then the calculated limits are approximately 21.0mm and 20.0mm respectively. 16 In a previous study by our group investigating complications in small eyes We found 1% of participants with small eyes were blind and 2% had low vision. When compared to all EPIC-Norfolk participants, blindness appears to be more common in those with a small eye (p=0.036, although case numbers were very low), but low vision was not (p=0.36). Unilateral visual impairment (defined by the worse seeing eye) was more common by all definitions (p≤ 0.001). When compared to data from population studies, the prevalence of visual impairment in EPIC-Norfolk participants is low overall, and values in those with small eyes is again low or similar. In the Blue Mountains Eye Study, 23 4.6% had a visual acuity of 6/12 (20/40) In summary, the small eye phenotype was more common than previously reported, and our study provides prevalence values in British adults. There are no standardized definitions for microphthalmos or nanophthalmos; however based on current evidence, subdivision by axial length of <21.0mm
for microphthalmos and <20.0mm for nanophthalmos appears reasonable.
People with small eyes appear more likely to be blind or have unilateral visual impairment. The estimated prevalence of glaucomatous optic neuropathy in our cohort appeared to be lower than expected and warrants further investigation. contributed to the conception and design of the study. RL contributed to the design of the study, and to data acquisition and management. DCB contributed to the conception and design of the study. KTK and PJF contributed to the conception and design of the study, and to data interpretation. All authors read and critically revised the manuscript. All authors approved the final manuscript.
DATA SHARING
The data sharing and preservation strategy in EPIC-Norfolk is in accordance with the Wellcome Trust data management and sharing policy. Full details about the study including contact information are on the website http://www.epic-norfolk.org.uk. Investigators wishing to work with EPIC data contact the EPIC management group through the website, letter, phone or fax, and proposals have to fulfil a number of criteria including that the work is within the bounds of consent given by participants and has been ethically reviewed and approved; there is no serious risk to the viability of continuing the cohort study for example, through offence to the participants from use of the data supplied; the science of the proposal has been satisfactorily peer reviewed and the proposal does not duplicate work already being done.
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